Position in DGX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$377,271
+$28,427 QoQ
Shares Held
1,780
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#683
of 1,090 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026WASHINGTON CAPITAL MANAGEMENT, INC holds $2,474,383 across 3 Diagnostics & Research names. DGX ranks #3 (15.2% of the industry book) .
All Filings in DGX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $377,271 | 1,780 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $348,844 | 1,780 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $308,883 | 1,780 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $343,996 | 1,805 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $351,176 | 1,955 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $762,246 | 4,505 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $679,624 | 4,505 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $699,401 | 4,505 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $616,644 | 4,505 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $599,660 | 4,505 | Shares | Sole | 2024-04-12 | |
| 2021-12-31 | $1,135,810 | 6,565 | Shares | Sole | 2023-09-18 | |
| 2021-09-30 | $974,303 | 6,705 | Shares | Sole | 2023-09-18 | |
| 2021-06-30 | $904,654 | 6,855 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $879,770 | 6,855 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $816,910 | 6,855 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $784,828 | 6,855 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $781,195 | 6,855 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $672,111 | 8,370 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||